Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Brotchie

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|November 25, 1998
Adjuncts to dopamine replacement: a pragmatic approach to reducing the problem of dyskinesia in Parkinson's diseaseJ M Brotchie
Current Opinion in Neurology|August 1, 1997
Novel approaches to the symptomatic treatment of parkinsonian syndromes: alternatives and adjuncts to dopamine-replacementJ M Brotchie
Annals of Neurology|April 13, 2000
The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's diseaseJ M Brotchie
Drugs & Aging|September 1, 1996
Potential of opioid antagonists in the treatment of levodopa-induced dyskinesias in Parkinson's diseaseB Henry, J M Brotchie
Experimental Neurology|April 1, 1997
Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expressionS Duty, J M Brotchie
European Journal of Pharmacology|July 25, 1995
Modulation of glutamate release by a kappa-opioid receptor agonist in rodent and primate striatumM P Hill, J M Brotchie
Movement Disorders : Official Journal of the Movement Disorder Society|November 8, 2006
Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesiaPenelope J Hallett, J M Brotchie
British Journal of Pharmacology|June 16, 1999
Control of glutamate release by calcium channels and kappa-opioid receptors in rodent and primate striatumM P Hill, J M Brotchie
European Journal of Pharmacology|June 17, 2000
5-HT(2C) receptor antagonists enhance the behavioural response to dopamine D(1) receptor agonists in the 6-hydroxydopamine-lesioned ratS H Fox, J M Brotchie
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 12, 2000
A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's diseaseJ E Nash, J M Brotchie
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Movement Disorders : Official Journal of the Movement Disorder Society|November 25, 1998
Adjuncts to dopamine replacement: a pragmatic approach to reducing the problem of dyskinesia in Parkinson's diseaseJ M Brotchie
Current Opinion in Neurology|August 1, 1997
Novel approaches to the symptomatic treatment of parkinsonian syndromes: alternatives and adjuncts to dopamine-replacementJ M Brotchie
Annals of Neurology|April 13, 2000
The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's diseaseJ M Brotchie
Drugs & Aging|September 1, 1996
Potential of opioid antagonists in the treatment of levodopa-induced dyskinesias in Parkinson's diseaseB Henry, J M Brotchie
Experimental Neurology|April 1, 1997
Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expressionS Duty, J M Brotchie
European Journal of Pharmacology|July 25, 1995
Modulation of glutamate release by a kappa-opioid receptor agonist in rodent and primate striatumM P Hill, J M Brotchie
Movement Disorders : Official Journal of the Movement Disorder Society|November 8, 2006
Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesiaPenelope J Hallett, J M Brotchie
British Journal of Pharmacology|June 16, 1999
Control of glutamate release by calcium channels and kappa-opioid receptors in rodent and primate striatumM P Hill, J M Brotchie
European Journal of Pharmacology|June 17, 2000
5-HT(2C) receptor antagonists enhance the behavioural response to dopamine D(1) receptor agonists in the 6-hydroxydopamine-lesioned ratS H Fox, J M Brotchie
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 12, 2000
A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's diseaseJ E Nash, J M Brotchie
Pageof 6